All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.
SIGN UP NOWSanofi is ready to spend money on manufacturing to prepare for the next global pandemic, and they aren't being shy about it. In the latest in a flurry of moves, the French drugmaker ...
READ MOREThe US Court of Appeals for the Fifth Circuit on Tuesday upheld the Federal Trade Commission’s ruling that generic drugmaker Impax Laboratories should be charged with antitrust violations ...
READ MOREAstraZeneca's PARP inhibitor Lynparza has raced out to blockbuster sales on the premise of killing tumor cells by inhibiting their ability to adequately heal. But Lynparza isn't a perfect ...
READ MOREEnough with the waiting. President Joe Biden needs to embrace the FDA during this pandemic and kickstart the Senate confirmation process for the next permanent commissioner.
READ MORE